Condition
Predisposition, Genetic
Total Trials
6
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Enrolling By Invitation2
Completed2
Terminated1
Recruiting1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06450171Not ApplicableRecruiting
Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Population: The INFORM Study
NCT03472807Not ApplicableTerminatedPrimary
EXOme Rare Cancers in Children (EXOCARE)
NCT06584994Enrolling By InvitationPrimary
Investigating the Role of Genetics in Disease Predisposition
NCT04848142Completed
Psychosocial Impact of Disclosing Cancer Predisposition Genetic Testing Results During Childhood
NCT04419896Enrolling By InvitationPrimary
The Informed Genetics Annotated Patient Registry
NCT03982446Completed
Germline Mutations in Pancreatic Adenocarcinoma
Showing all 6 trials